Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001654954-20-000677
Filing Date
2020-01-23
Accepted
2020-01-23 08:30:50
Documents
1
Period of Report
2020-01-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 section16.html 4  
1 FORM 4 section16.xml 4 2909
  Complete submission text file 0001654954-20-000677.txt   4501
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Issuer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AYTU BIOSCIENCE, INC. 373 INVERNESS PARKWAY, SUITE 206 ENGLEWOOD CO 80112
Business Address
Mehta Ketan Bhupatrai (Reporting) CIK: 0001758559 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38247 | Film No.: 20540491